These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33879420)

  • 1. COVID-19 related callback in blood donors; Outcomes in blood donors and patients.
    Balagholi S; Maghsudlu M; Amini-Kafiabad S; Nazemi AM; Sotoudeh Anvari M
    Transfus Apher Sci; 2021 Aug; 60(4):103129. PubMed ID: 33879420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components.
    Politis C; Papadaki M; Politi L; Kourti G; Richardson C; Asariotou M; Tsakris A; Mentis A
    Transfus Clin Biol; 2021 Feb; 28(1):55-59. PubMed ID: 33096208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.
    Corman VM; Rabenau HF; Adams O; Oberle D; Funk MB; Keller-Stanislawski B; Timm J; Drosten C; Ciesek S
    Transfusion; 2020 Jun; 60(6):1119-1122. PubMed ID: 32361996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran.
    Rafiee MH; Kafiabad SA; Maghsudlu M
    Transfus Apher Sci; 2021 Apr; 60(2):103049. PubMed ID: 33468406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
    Voruz S; Gowland P; Eyer C; Widmer N; Abonnenc M; Prudent M; Masouridi-Levrat S; Duchosal MA; Niederhauser C
    Blood Transfus; 2020 Nov; 18(6):446-453. PubMed ID: 32203012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood and platelet transfusion from a donor with presymptomatic Covid-19.
    Liapis K; Papoutselis M; Vrachiolias G; Misidou C; Spanoudakis E; Bezirgiannidou Z; Pentidou A; Konstantinidis T; Kotsianidis I
    Ann Hematol; 2021 Aug; 100(8):2133-2134. PubMed ID: 33188469
    [No Abstract]   [Full Text] [Related]  

  • 7. Re-examine the transfusion transmitted risk of SARS-CoV-2 virus during a major COVID-19 outbreak in 2022.
    Ng SC; Chu AWH; Chan WM; Yip CCY; Leung KH; So CK; Leung JNS; To KKW; Lee CK
    Transfus Med; 2023 Aug; 33(4):315-319. PubMed ID: 37286528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic blood donor demographics - Do changes impact blood safety?
    Vassallo RR; Bravo MD; Kamel H
    Transfusion; 2021 May; 61(5):1389-1393. PubMed ID: 33554333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy.
    Pati I; Velati C; Mengoli C; Franchini M; Masiello F; Marano G; Veropalumbo E; Vaglio S; Piccinini V; Pupella S; Liumbruno GM
    Transfus Med; 2021 Jun; 31(3):200-205. PubMed ID: 33694217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 in the attendance of blood donors and production on a Brazilian Blood Centres.
    Silva-Malta MCF; Rodrigues DOW; Chaves DG; Magalhães NNS; Ribeiro MA; Cioffi JGM; Martins ML
    Transfus Med; 2021 Jun; 31(3):206-212. PubMed ID: 33118220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood supply sufficiency and safety management in Iran during the COVID-19 outbreak.
    Maghsudlu M; Eshghi P; Amini Kafi-Abad S; Sedaghat A; Ranjbaran H; Mohammadi S; Tabatabai SM
    Vox Sang; 2021 Feb; 116(2):175-180. PubMed ID: 32996588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis.
    Van Remoortel H; Moorkens D; Avau B; Compernolle V; Vandekerckhove P; De Buck E
    Vox Sang; 2019 May; 114(4):297-309. PubMed ID: 30972765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS-CoV-2.
    Spekman MLC; Ramondt S; Quee FA; Prinsze FJ; Huis In 't Veld EMJ; van den Hurk K; Merz EM
    Transfusion; 2021 Jun; 61(6):1822-1829. PubMed ID: 33634876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.
    Mandel M; Gurevich M; Mandelboim M; Amital H; Achiron A
    Isr Med Assoc J; 2021 Jan; 23(1):7-10. PubMed ID: 33443334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of COVID-19 on blood safety and availability in the Islamic Republic of Iran.
    Divkolaye N; Arabkhazaeli A; Hajibeigi B; Eshghi P
    East Mediterr Health J; 2022 Nov; 28(11):823-828. PubMed ID: 36515446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 transmission and blood transfusion: A case report.
    Cho HJ; Koo JW; Roh SK; Kim YK; Suh JS; Moon JH; Sohn SK; Baek DW
    J Infect Public Health; 2020 Nov; 13(11):1678-1679. PubMed ID: 32405329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four decades of National Blood Service in Iran: outreach, prospect and challenges.
    Pourfathollah AA; Hosseini Divkolaye NS; Seighali F
    Transfus Med; 2015 Jun; 25(3):138-43. PubMed ID: 26040645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency.
    Kiely P; Hoad VC; Seed CR; Gosbell IB
    Vox Sang; 2021 Feb; 116(2):155-166. PubMed ID: 32965726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party.
    Stanley J; Busch MP; Erikstrup C; Galel SA; Holmberg JA; Lewin A; O'Brien SF; Osiowy C; Patidar G; Russell WA; Spencer BR; Higgs C;
    Vox Sang; 2024 Oct; 119(10):1122-1125. PubMed ID: 39054253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.